2021
DOI: 10.1016/j.ebiom.2020.103147
|View full text |Cite
|
Sign up to set email alerts
|

Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes

Abstract: Background Comprehensive proteomics profiling may offer new insights into the dysregulated metabolic milieu of type 2 diabetes, and in the future, serve as a useful tool for personalized medicine. This calls for a better understanding of circulating protein patterns at the early stage of type 2 diabetes as well as the dynamics of protein patterns during changes in metabolic status. Methods To elucidate the systemic alterations in early-stage diabetes and to investigate … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 42 publications
3
18
0
Order By: Relevance
“…The characteristics of T2D and its association with the epidemic of obesity have been extensively studied, but relatively little is known about the incidence of lean diabetes and the progression of disease during treatment 28 . The results presented here support the notion that broad biochemical alterations are present already at the onset of type 2 diabetes and that protein profiling could deliver individualized health assessments of cardiometabolic diseases 4 , 17 . The anthropometrical parameters of the T2D cohort allowed us to stratify the patients into two distinct groups based on BMI and an analysis of the protein profiles between the health individuals and the T2D patients at base line (visit 1) revealed several proteins, that could be useful for early detection of disease based solely on protein profiles.…”
Section: Discussionsupporting
confidence: 81%
See 2 more Smart Citations
“…The characteristics of T2D and its association with the epidemic of obesity have been extensively studied, but relatively little is known about the incidence of lean diabetes and the progression of disease during treatment 28 . The results presented here support the notion that broad biochemical alterations are present already at the onset of type 2 diabetes and that protein profiling could deliver individualized health assessments of cardiometabolic diseases 4 , 17 . The anthropometrical parameters of the T2D cohort allowed us to stratify the patients into two distinct groups based on BMI and an analysis of the protein profiles between the health individuals and the T2D patients at base line (visit 1) revealed several proteins, that could be useful for early detection of disease based solely on protein profiles.…”
Section: Discussionsupporting
confidence: 81%
“…The complete list of assessed clinical variables is available in Supplementary Data 2 . The second cohort (type 2 diabetes) consisted of 48 individuals also recruited from the SCAPIS study, with no history of diabetes, and who were diagnosed during the population-based screening 17 . The sample collection in combination with clinical chemistry analysis of 30 parameters as described in the wellness study, anthropometric measurements as well as analysis of insulin, C-peptide, and the homeostatic model assessment of insulin resistance (HOMA-IR) were conducted at the start of the trial (visit 1) and after approximately 1 month (visit 2) and 3 months (visit 3) of treatment (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“… 30 Similarly, plasma expression of HGF, IL-6, FGF-21, CDCP1 and IL-18R1 have been identified among the top 30 proteins associated with newly diagnosed type 2 diabetes. 31 It is interesting to note that four of the proteins increased in diabetes were also increased in patients with MI deep periodontal pockets. We have previously reported in the PAROKRANK cohort that undetected diabetes was more frequent among participants with severe periodontitis.…”
Section: Discussionmentioning
confidence: 97%
“…An important effort to understand the biology of the host-virus response is to move towards comprehensive proteome profiling of host proteins in blood in response to viral infections, not only to understand the basis for disease, but also to facilitate precision medicine efforts aimed at stratification and monitoring of patients before and during therapeutic interventions (Gummesson et al , 2021; Zhong et al , 2021; Zhong et al , 2020). The objective is thus to probe the circulating plasma proteome of individuals with sensitive and specific assays that can allow massive sample throughput.…”
Section: Introductionmentioning
confidence: 99%